The total revenue of the rotator cuff injury treatment market was USD 1,098.4 million in 2022, which will rise at a rate of 5.1% in the years to come, to reach USD 1,633.5 million by 2030.
 |
| To learn more about this report: https://bit.ly/3Iny3y2 |
Surgical treatment had the largest share of revenue in the past of about 55%, and it will maintain its dominance in the years to come. This is because of the high frequency of rotator cuff injuries and the promising medical compensation policies for their treatment.
Moreover, the increasing consciousness of the assistances of an arthroscopic repair, such as, its low risk of complications, fast recovery, and low frequency of post-operative infections, will contribute significantly to the growth of this category.
Moreover, the physiotherapy category will observe a considerable growth in the future. This is because athletes frequently use this as the first method for managing injuries. Moreover, the surge in the elderly population is a major factor powering the category growth, as aged people are more inclined toward this treatment.
North America is the largest contributor to the rotator cuff injury treatment market with around 45%, as per P&S Intelligence. This has a lot to do with the continuing R&D, increasing number of product launches, and commercialization of state-of-the-art treatments for rotator cuff injuries.
Furthermore, the growing funding and number of partnerships amongst major companies, promising regulatory setting for rotator cuff surgeries, along with the supportive policies of the government for the sale of related goods boost the industry. Besides, the considerable engagement of the people in sports will let the continent remain on top during the years to come.
Because of the increasing cases of shoulder injuries in the world, the demand for rotator cuff injury treatment will continue to rise by the end of this decade.
